Zivo Bioscience, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2017 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zivo Bioscience, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q1 2022.
  • Zivo Bioscience, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $571K, a 41.5% decline year-over-year.
  • Zivo Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.69M, a 9.35% decline from 2021.
  • Zivo Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.97M, a 138% increase from 2020.
  • Zivo Bioscience, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $1.25M, a 65.4% decline from 2019.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $571K -$404K -41.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q1 2021 $975K -$221K -18.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $1.2M +$1.17M +4780% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $24.5K -$259K -91.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $283K +$263K +1324% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q1 2017 $19.9K Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.